Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular diseases (CVD) are a leading global cause of mortality, accounting for 17.9 million deaths annually.
• Current treatments for CVD often fall short, necessitating innovative approaches like Cardiac Tissue Engineering (CTE).
• CTE aims to regenerate diseased cardiac tissue using a combination of biomaterials and cells.

Purpose of the Study:

• To review the application of natural biomaterials in Cardiac Tissue Engineering (CTE).
• To highlight the properties and efficacy of specific natural biomaterials for cardiac regeneration.
• To assess the potential of CTE for future clinical applications in treating cardiovascular diseases.

Main Methods:

• Focus on natural biomaterials for CTE, including fibrinogen, collagen, alginate, silk, and Polyhydroxyalkanoates (PHAs).
• Review of pre-clinical studies utilizing various cell types (stem cells, iPSCs, ESCs) with these biomaterials.
• Analysis of material properties supporting cell attachment, growth, differentiation, and functional tissue formation.

Main Results:

• Natural biomaterials demonstrate high biocompatibility and sustainability.
• Fibrinogen, collagen, alginate, and silk are effective in supporting cardiac cell development.
• Pre-clinical models show enhanced post-myocardial infarction (MI) cardiac function when using these biomaterials with cells.

Conclusions:

• Natural biomaterials are highly promising for Cardiac Tissue Engineering (CTE).
• CTE holds significant potential for clinical solutions to cardiovascular diseases (CVD).
• Successful CTE could substantially reduce CVD-related mortality rates.